Clinical trial
An International Multicentre Open-label Comparative Therapeutic Exploratory Trial to Investigate the Role of a New Neonatal Formulation of Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period
NCT03311178 is registered in ClinicalTrials.gov with Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An International Multicentre Open-label Comparative Therapeutic Exploratory Trial to Investigate the Role of a New Neonatal Formulation of Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period
- Lead sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz
- Phase
- Phase 1/2
- Overall status
- Terminated
- Start date
- May 30, 2014
- Completion date
- October 10, 2017
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.